Standout Papers

GLP-1 receptor agonists i... 2020 2026 2022 2024 2020 2021 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
    2020 942 citations Michael A. Nauck, Daniel R. Quast et al. Molecular Metabolism
  2. The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
    2021 231 citations Michael A. Nauck, Daniel R. Quast et al. Diabetes Obesity and Metabolism
  3. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
    2021 182 citations Michael A. Nauck, Jakob Wefers et al. The Lancet Diabetes & Endocrinology

Immediate Impact

6 from Science/Nature 71 hit
Sub-graph 1 of 22

Citing Papers

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Hit
Metabolic Dysfunction–Associated Steatotic Liver Disease
2025 Hit
2 intermediate papers

Works of Jakob Wefers being referenced

The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
2021 Hit
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
2020 Hit

Author Peers

Author Last Decade Papers Cites
Jakob Wefers 972 601 548 431 317 13 1.8k
Gitte Hansen 822 533 518 420 523 31 1.9k
Katrin Hücking 812 344 363 475 162 15 1.3k
Jean‐Pierre Gutzwiller 1070 397 545 637 610 27 2.2k
Louis Vignati 1047 352 262 418 302 24 1.8k
Kristy M. Heppner 581 420 734 468 670 27 1.7k
Alice E. Adriaenssens 937 528 306 784 348 22 1.6k
Bernhard Kreymann 1346 477 389 926 393 23 2.3k
Michael Tanen 885 971 658 320 129 21 2.2k
Mónica Imbernón 304 497 602 352 426 15 1.5k
Trine Ryberg Clausen 786 509 887 1060 281 39 2.0k

All Works

Loading papers...

Rankless by CCL
2026